Asthma in US Seniors: Part 2. Treatment. Seeing Through the Glass Darkly

American Journal of Medicine

Volumn 122, Issue 2, 2009, Pages 109-113

  deShazo, Richard D ^a   Stupka, J Eric ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aging; Asthma; Elderly; Obstructive lung disease; Treatment

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUORINATED HYDROCARBON; FLUTICASONE; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB; PLACEBO; PRANLUKAST; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

AGED; ASTHMA; CATARACT; COMORBIDITY; DISEASE SEVERITY; DRUG MEGADOSE; DRY POWDER; ELDERLY CARE; HUMAN; HYPOKALEMIA; INTRAOCULAR HYPERTENSION; METERED DOSE INHALER; NEBULIZER; OPEN ANGLE GLAUCOMA; POWDER INHALER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SYMPTOMATOLOGY; TACHYCARDIA; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; UNITED STATES;

AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 58649096361     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.09.019     Document Type: Review

References (33)

1. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma (1991), National Heart, Lung, and Blood Institute, Bethesda, MD (NIH Publication No. 91-3642)
2. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma (1997), National Heart, Lung, and Blood Institute, Bethesda, MD (NIH Publication No. 97-4051)
3. National Asthma Education and Prevention Program. Expert Panel Report Update: Guidelines for the Diagnosis and Management of Asthma (2002), National Heart, Lung, and Blood Institute, Bethesda, MD (NIH Publication No. 02-5074)
4. National Asthma Education and Prevention Program. Expert Panel Report III: Guidelines for the Diagnosis and Management of Asthma (2007), National Heart, Lung, and Blood Institute, Bethesda, MD (NIH Publication No. 08-4051)
5. National Asthma Education and Prevention Program. Working Group Report: Considerations for Diagnosis and Managing Asthma in the Elderly (1996), National Institute of Heart, Lung and Blood Institute, Bethesda, MD (NIH Publication No 96-3662)
6. Sitar D., Aoki F., Warren C., et al. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest 103 (1993) 771-776
7. Horiguchi T., Tachikawa S., Kondo R., et al. Comparative evaluation of the leukotriene receptor antagonists pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma. Arzneimittelforschung 57 (2007) 87-91
8. Donateo L., Gerardi R., and Cantini L. A new spacer device for administration of inhaled salbutamol: use in elderly asthmatics. Adv Ther 13 (1996) 292-300
9. Dyer C., Singh S., Stockley R., Sinclair A., and Hill S. The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax 57 (2002) 34-38
10. Enright P., McClelland R., Newman A., et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest 116 (1999) 603-613
11. Connolly M., Crowley J., Charan N., et al. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 47 (1992) 410-413
12. Kronenberg R., and Drage C. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest 52 (1973) 1812-1819
13. 2. J Appl Physiol (1984) 1143-1150
14. Vergnenegre A., Antonini M., Bonnaud F., et al. Comparison between late onset and childhood asthma. Allergol Immunopathol 20 (1992) 190-196
15. Inman W. Monitoring of adverse reactions to drugs in the United Kingdom. Proc R Soc Med 63 (1970) 1302-1304
16. Robin E., and McCauley R. Sudden cardiac death in bronchial asthma and inhaled beta-adrenergic agonists. Chest 101 (1992) 1699-1702
17. Salpeter S., Ormiston T., and Salpeter E. Cardiovascular effects of B-agonists in patients with asthma and COPD: a meta-analysis. Chest 125 (2004) 2309-2321
18. Nelson H., Weiss S., Bleecker E., et al. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129 (2006) 15-26
19. Donohue J. Therapeutic responses in asthma and COPD: bronchodilators. Chest 126 (2004) 125-137
20. Westby M., Benson M., and Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 3 (2004) CD003269
21. Rodrigo G., and Castro-Rodriguez J. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60 (2005) 740-746
22. Sin D., and Tu J. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 580-584
23. Leone F., Fish J., Szefler S., and West S. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma and Immunology, and American College of Allergy, Asthma and Immunology. Chest 124 (2003) 2329-2340
24. Garbe E., LeLorier J., Boivin J., and Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 277 (1997) 722-727
25. Garbe E., Suissa S., and LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 280 (1998) 539-543
26. Sin D., and Tu J. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 119 (2001) 720-725
27. Korenblat P., Kemp J., Scherger J., et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol 84 (2000) 217-225
28. Bousquet J., Cabrera P., Berkman N., et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60 (2005) 302-308
29. Ho S., O'Mahony M.S., Steward J., et al. Inhaler technique in older people in the community. Age Ageing 33 (2004) 185-188
30. Goodman D., Israel E., Rosenberg M., et al. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 150 (1994) 1256-1261
31. Brockelbank D., Ram F., Wright J., et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 5 (2001) 1-149
32. Dolovich M., Ahrens R., Hess D., et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy and Immunology. Chest 127 (2005) 335-371
33. Allen S. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 26 (1997) 83-86